Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review.

  • Doyle L
  • Ehrenkranz R
  • Halliday H
 et al. 
  • 1

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Abstract

BACKGROUND: Corticosteroids have been used widely after birth in preterm infants with respiratory failure; hydrocortisone may be preferable to other corticosteroids for this purpose.

OBJECTIVES: To determine if postnatal hydrocortisone is useful to prevent or treat bronchopulmonary dysplasia (BPD) in preterm infants.

METHODS: Randomised controlled trials (RCTs) of postnatal hydrocortisone therapy to prevent or treat BPD were sought. Data regarding clinical outcomes including mortality, BPD, death or BPD, complications during the primary hospitalisation, and long-term outcome were abstracted and analysed using RevMan 5.

RESULTS: Eight RCTs enrolling a total of 880 participants were eligible. In all trials treatment was started in the first week of life; there were no trials of treatment started in infants who were chronically ventilator-dependent after the first week of life with established or evolving BPD. A meta-analysis of the available trials demonstrated little evidence for a direct effect of hydrocortisone on the rates of BPD, mortality, or the combined outcome of BPD or mortality. Hydrocortisone in the doses used in these eight studies had few beneficial or harmful effects; the notable exception was an increase in gastrointestinal perforation.

CONCLUSIONS: Postnatal hydrocortisone in the doses and regimens used in the reported trials has few beneficial or harmful effects and cannot be recommended for prevention of BPD. There are no randomised trials to substantiate the use of hydrocortisone in chronically ventilator-dependent infants with established or evolving BPD.

Author-supplied keywords

  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents: therapeutic use
  • Bronchopulmonary Dysplasia
  • Bronchopulmonary Dysplasia: drug therapy
  • Bronchopulmonary Dysplasia: mortality
  • Bronchopulmonary Dysplasia: prevention & control
  • Humans
  • Hydrocortisone
  • Hydrocortisone: therapeutic use
  • Infant
  • Intestinal Perforation
  • Intestinal Perforation: etiology
  • Newborn
  • Premature
  • Randomized Controlled Trials as Topic
  • Survival Rate
  • Treatment Outcome
  • bronchopulmonary dysplasia treatment
  • hydrocortisone ؒ bronchopulmonary dysplasia
  • infants ؒ mortality
  • rate ؒ cerebral palsy
  • ؒ

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Lex W Doyle

  • Richard a Ehrenkranz

  • Henry L Halliday

  • A Ehrenkranz

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free